AMPK/Ulk1-dependent autophagy as a key mTOR regulator in the context of cell pluripotency

Irina I. Suvorova,Valery A. Pospelov
DOI: https://doi.org/10.1038/s41419-019-1501-9
2019-03-18
Cell Death and Disease
Abstract:<p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Comment <span> | </span><abbr>Open</abbr><span> | </span><a href="#article-info">Published: <time>18 March 2019</time></a><i>Cell Death &amp; Disease</i><b><span>volume</span> 10</b>, Article number: <span>260</span> (<span>2019</span>) <span> | </span><a href="/articles/s41419-019-1501-9.ris"> Download Citation </a>The mechanisms providing high-quality control of intracellular components are critical in embryonic development and, accordingly, must be highly effective in embryonic stem cells (ESCs) generating all types of adult tissues. Recently, it has been shown that defective ESCs in embryogenesis are eliminated from the population through the mammalian target of rapamycin (mTOR)/p53 mechanism<sup><a href="/articles/s41419-019-1501-9#ref-CR1">1</a></sup>. Defective ESCs are the cells that, in response to differentiation stimuli, are not able to exit from pluripotency, remaining undifferentiated. The underlying reason for the resistance to differentiation is dysregulation of signal transduction pathways leading to the mTOR pathway activation<sup><a href="/articles/s41419-019-1501-9#ref-CR1">1</a></sup>. The mTOR pathway induces protein synthesis and cell growth in response to mitogenic signaling in the presence of high nutrient/energy levels and low stress. The deletion of the <i>mtor</i> gene results in embryonic lethality shortly after implantation, indicating its pivotal role in differentiation<sup><a href="/articles/s41419-019-1501-9#ref-CR2">2</a></sup>. Based on this the pluripotency establishment in vivo occurs in the absence of the mTOR pathway but requires autophagy activation that is an antagonist of the mTOR activity. Autophagy is suppressed in oocytes but it is massively induced in a short time after fertilization<sup><a href="/articles/s41419-019-1501-9#ref-CR3">3</a></sup>. At the same time, maternal proteins and organelles rapidly degrade and are replaced by embryonic genome-derived proteins, and consequently fertilized oocyte undergoes a large-scale intracellular rearrangement in a process called maternal-to-zygotic transition. Autophagy is responsible for this degradation, because it allows carrying out of large-scale restructuring of intracellular components by generating enough amino acids for newly synthesized proteins, in particular pluripotency-associated (PA) proteins. A key role of autophagy in the homeostasis of ESCs has already established. It was shown that autophagy regulates the levels of PA such as Oct4, Sox2, Nanog, and Klf4, and quantitative imbalances of these affect differentiation potential of cells<sup><a href="/articles/s41419-019-1501-9#ref-CR4">4</a></sup>. Therefore, disturbance of autophagy may be crucial for the development of differentiation-resistant cells and their inclusion in the final ESC- or induced pluripotent stem cell (iPSC)-derived cell product that will produce tumors after transplantation. Observed loss of the mTOR activity in differentiation-resistant cells can be linked to persistent autophagy, being a barrier to exit from pluripotency.AMP-activated protein kinase (AMPK)-dependent Ulk1 phosphorylations are a direct mechanism to induce autophagy in cells. In the last issue of <i>Cell Death Discovery</i>, Suvorova et al.<sup><a href="/articles/s41419-019-1501-9#ref-CR5">5</a></sup> identified that the AMPK/Ulk1-dependent autophagy promotes pluripotency of mouse ESCs (mESCs) under resveratrol treatment. Resveratrol is a natural polyphenolic compound showing beneficial effects on different animal models via autophagy induction. We have treated a serum-based culture of mESCs that are characterized as heterogeneous according to the degree of differentiation of individual cells by resveratrol. It was found that resveratrol makes mESC population more homogeneous and this was confirmed by morphological results and increased expressions of PA proteins Oct4, Sox2, Nanog, Klf4, and SSEA-1. Enhanced pluripotency is correlated with high autophagic flux in resveratrol-treated cells, suggesting autophagic control of pluripotency. Autophagy was executed via AMPK/Ulk1 pathway activation and mTOR complex 1 (mTORC1) pathway inhibition. Resveratrol seems to maintain pluripotency through downregulation of the mTORC1/Ulk1 pathway. In order to prove this, we had used an inhibitor of Ulk1 activity and respectively Ulk1-dependent autophagy MRT68921. According to the data obtained, resveratrol induces LC3 protein accumulati <p>-Abstract Truncated-</p>
cell biology
What problem does this paper attempt to address?